您现在的位置是:幻浪视界 > 知识
Weight regain happens 4x faster after stopping GLP
幻浪视界2026-01-31 20:34:29【知识】3人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(87323)
上一篇: 四年级状物作文:我家兔子真可爱
下一篇: 设计楼房有哪些技巧 设计楼房注意事项
相关文章
- Vụ CIPCO: Thay đổi tội danh của bị can tặng quà cựu Bí thư, Chủ tịch Cần Thơ cũ
- “楚天羽王”总决赛决战咸宁,湖北顶尖羽毛球俱乐部竞逐羽球之巅
- 39 ESSENTIAL Travel Apps for iPhone & Android in 2025
- How to Plan a Trip in 2025: My Full
- 《白银之城》开启封闭B测招募 虚幻5开放世界ARPG
- QQ拼音输入法如何打出特殊符号和颜文字
- [新浪彩票]足彩25190期冷热指数:阿森纳防冷平
- 国漫盘点:综漫最值得追随的老大
- 买的橙子没试吃的甜 原因竟是出现在小贩的刀上...
- 英雄联盟海克斯大乱斗法转物怎么玩
站长推荐
友情链接
- 中国乒协拟聘秦志戬为国乒总教练 肖战为副总教练
- U23国足刚绝杀澳大利亚,足协就官宣名帅将正式接手,让球迷意外
- 社区垃圾分类如何推进开展?
- 龙族卡塞尔之门周年庆新手入坑攻略2025
- 新三国志曹操传沙盘1750
- 澳大利亚公开赛皮特森领先2杆 丁文一维持前十位
- 港股AI板块全面爆发 美图公司涨超11%
- 市场反应不及预期 苹果iPhone Air年末或将减产百万台
- CHC杰士马主俱乐部2岁公马“玄机”澳洲赛马夺冠
- 世界挑战赛第二轮五人并列领先 舍夫勒落后一杆
- 初三议论文:谈诚信 17
- “老李,敬你”:“小放光明”的夏秋与以后
- 日媒曝日本排球王子高桥蓝 同时与网红和AV女优交往
- เลือกตั้งเมียนมา: 7 สิ่งต้องรู้เกี่ยวกับการเลือกตั้งเมียนมา 2025
- สมัคร สส.เขตทั่วประเทศวันแรก รวม 3,092 คน กทม.มากสุด 449 คน
- 传奇里怪物掉落的奖励物品靠抢
- 初三议论文:谈诚信 18
- 格鲁吉亚前国防部长因涉嫌组织策划未遂政变被逮捕
- 短池世锦赛女子50蛙决赛 唐钱婷再破亚洲纪录夺冠
- สหรัฐฯ พบเอกสารเอปสตีน เพิ่มกว่าล้านฉบับ คาดใช้เวลาหลายสัปดาห์ก่อนจะเปิดเผยได้






